Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C.

MLA

Thierry Bizollon, et al. “Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C.” Transplantation, vol. 79, no. 3, Feb. 2005, pp. 325–29. EBSCOhost, https://doi.org/10.1097/01.tp.0000149499.78996.b3.

APA

Thierry Bizollon, Mustapha Adham, Pierre Pradat, Michelle Chevallier, Christian Ducerf, Jacques Baulieux, Fabian Zoulim, & Christian Trepo. (2005). Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C. Transplantation, 79(3), 325–329. https://doi.org/10.1097/01.tp.0000149499.78996.b3

Chicago

Thierry Bizollon, Mustapha Adham, Pierre Pradat, Michelle Chevallier, Christian Ducerf, Jacques Baulieux, Fabian Zoulim, and Christian Trepo. 2005. “Triple Antiviral Therapy with Amantadine for IFN-Ribavirin Nonresponders with Recurrent Posttransplantation Hepatitis C.” Transplantation 79 (3): 325–29. doi:10.1097/01.tp.0000149499.78996.b3.